Neuro-immune ChATing protects the heart

Area of Science:

• Cardiovascular Physiology
• Neuroimmunology
• Molecular Cardiology

Background:

• Autonomic imbalance, particularly parasympathetic withdrawal, is a key feature of heart failure (HF).
• The precise mechanisms by which parasympathetic dysfunction contributes to HF pathogenesis remain incompletely understood.
• Understanding these mechanisms is crucial for developing novel therapeutic strategies for HF.

Purpose of the Study:

• To investigate the mechanistic role of parasympathetic signaling in HF.
• To explore the potential of targeted neural stimulation to mitigate HF progression.
• To elucidate the cellular and molecular pathways involved in the protective effects of parasympathetic activation.

Main Methods:

• Utilized optogenetics to selectively stimulate choline acetyltransferase (ChAT)-expressing neurons in the dorsal vagal motor nucleus (DVMN).
• Assessed the impact of DVMN stimulation on cardiac function and inflammatory markers in HF models.
• Investigated the role of nicotinic acetylcholine receptor α7 (α7nAChR) signaling in mediating the observed effects.

Main Results:

• Targeted optogenetic stimulation of ChAT+ neurons in the DVMN demonstrated a protective effect against HF.
• This stimulation led to the reprogramming of inflammatory CCRL2+ cardiac macrophages.
• The protective effects were mediated through the activation of the α7nAChR signaling pathway.

Conclusions:

• Parasympathetic nervous system activity, specifically via ChAT+ neurons in the DVMN, plays a critical protective role in HF.
• Targeted stimulation of these neurons can reprogram pro-inflammatory cardiac macrophages, offering a potential therapeutic avenue.
• The α7nAChR pathway is a key mediator of these beneficial effects in the context of HF.